HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer

Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

Comment: Adjuvant ipilimumab in high-risk melanoma

Comment: PD-1 targeting MK-3475 gives long-term responses in melanoma

Comment: Immunotherapy combo increases median survival in advanced melanoma

Success for ipilimumab and nivolumab combo in advanced melanoma

Comment: CALGB/SWOG 80405 study on chemo combos in colorectal

Discontinuing statins near the end of life is safe, improves patient quality of life

T-VEC injections into melanoma lesions show significant response rate

Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer

Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence

ASCO 2014 roundup